| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |